TY - JOUR
T1 - Avirulent Salmonella typhimurium Δcya Δcrp oral vaccine strains expressing a streptococcal colonization and virulence antigen
AU - Curtiss, Roy
AU - Goldschmidt, Raúl M.
AU - Fletchall, Norah B.
AU - Kelly, Sandra M.
N1 - Funding Information:
The authors are grateful to Paul Gulig and Steven Tinge for scientific advice during the course of these studies, Jack Diani and Dan Piatchek for assistance with the animal experimentation and Margaret Buon- cristiani for assistance in preparation of the manuscript. Research was supported by grants from Molecular Engineering Associates and from the United States Public Health Service (DE06669 and DE06673).
PY - 1988/4
Y1 - 1988/4
N2 - Salmonella typhimurium SR-11 strains lacking adenylate cyclase and the cyclic AMP receptor protein (CRP) due to deletion (Δ) mutations in the cya and crp genes, respectively, are avirulent for mice and induce high level protective immunity against subsequent challenge with wild-type virulent S. typhimurium SR-11 cells. The avirulence of these Δcya Δcrp mutants has been enhanced by elimination of the 100 kb virulence plasmid pStSR100 without impairing immunogenicity. The present report confirms the avirulence and immunogenicity of these mutant strains, demonstrates that immunization of both four- and eight-week-old mice has no adverse effect on weight gain, and that immunity lasts at least ninety days following initial immunization. Avirulent S. typhimurium strains have been endowed with the ability to produce several streptococcal colonization and virulence antigens for the purpose of constructing recombinant bivalent oral vaccine strains. Important antigenic determinants of the Streptococcus sobrinus surface protein antigen A (SpaA), presumed to be a critical colonization antigen of S. sobrinus, are expressed at high level by the Δcya Δcrp S. typhimurium strains. The recombinant vaccine strains are stable in vitro and in animals (for a period of at least eight days) where they localize to the gut-associated lymphoid tissue (GALT).
AB - Salmonella typhimurium SR-11 strains lacking adenylate cyclase and the cyclic AMP receptor protein (CRP) due to deletion (Δ) mutations in the cya and crp genes, respectively, are avirulent for mice and induce high level protective immunity against subsequent challenge with wild-type virulent S. typhimurium SR-11 cells. The avirulence of these Δcya Δcrp mutants has been enhanced by elimination of the 100 kb virulence plasmid pStSR100 without impairing immunogenicity. The present report confirms the avirulence and immunogenicity of these mutant strains, demonstrates that immunization of both four- and eight-week-old mice has no adverse effect on weight gain, and that immunity lasts at least ninety days following initial immunization. Avirulent S. typhimurium strains have been endowed with the ability to produce several streptococcal colonization and virulence antigens for the purpose of constructing recombinant bivalent oral vaccine strains. Important antigenic determinants of the Streptococcus sobrinus surface protein antigen A (SpaA), presumed to be a critical colonization antigen of S. sobrinus, are expressed at high level by the Δcya Δcrp S. typhimurium strains. The recombinant vaccine strains are stable in vitro and in animals (for a period of at least eight days) where they localize to the gut-associated lymphoid tissue (GALT).
KW - Salmonella typhimurium avirulent mutants
KW - Streptococcus sobrinus colonization antigen
KW - bivalent recombinant oral vaccine strains
UR - http://www.scopus.com/inward/record.url?scp=0023819409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023819409&partnerID=8YFLogxK
U2 - 10.1016/S0264-410X(88)80020-3
DO - 10.1016/S0264-410X(88)80020-3
M3 - Article
C2 - 3291452
AN - SCOPUS:0023819409
SN - 0264-410X
VL - 6
SP - 155
EP - 160
JO - Vaccine
JF - Vaccine
IS - 2
ER -